MedTrace Logo

Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy

NCT04567251 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2025-05-14

No results posted yet for this study

Summary

This study represents a survivorship protocol that focuses on cognition and health-related quality of life (HRQoL) in cancer patients that have received prior brain irradiation. The primary purpose of this study is to assess the feasibility of using a digital symptom tracking application focused on HRQoL and cognition in cancer survivors who received brain irradiation.

Conditions

Interventions

OTHER

Noona® application

A digital symptom tracking application focused on Health-Related Quality of Life (HRQOL) and cognition in cancer survivors who received brain irradiation

Sponsors & Collaborators

Principal Investigators

  • Katherine Peters, MD, PhD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2024-05-29
Completion
2024-05-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04567251 on ClinicalTrials.gov